Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07536412 · ClinicalTrials.gov registry record · NA
Decision Aid Efficacy in Low Risk Thyroid Cancer
A NA study, sponsored by University of Maryland, Baltimore.
- Not yet
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT07536412: Clinical Trial NA study, sponsored by University of Maryland, Baltimore.
NCT07536412 is a NA study that has not yet begun recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07536412, a NA study, has not yet begun recruiting, sponsored by University of Maryland, Baltimore.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is similar across the 3 main treatment options. It can be difficult for patients to choose a treatment option, especially when feeling anxious about the cancer diagnosis. In this study, enrolled patients will receive a decision aid after finding out they have cancer but before meeting a surgeon. This decision aid is a pamphlet. It gives information about the treatment options and a list of questions for patients to ask their surgeons at their clinic visit. The investigators will test whether this aid changes patient decision anxiety and decision readiness.
Primary Outcome
Decisional conflict will be quantified with the Decisional Conflict Scale (DCS). Range: 0 \[no decisional conflict\] to 100 \[extremely high decisional conflict\]
Interventions
- OTHER Decision Aid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2026-05-15 |
| Est. Completion | 2029-06-15 |
| Phase | NA |
What is known before NCT07536412 opens enrollment
NCT07536412 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Decision Aid is the first listed.
NCT07536412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07536412 about?
NCT07536412 is a clinical study titled "Decision Aid Efficacy in Low Risk Thyroid Cancer". Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is ...
What is the current status of trial NCT07536412?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 34 participants. The study started on 2026-05-15. Estimated completion is 2029-06-15.
What interventions are being tested in trial NCT07536412?
The interventions under investigation include: Decision Aid (OTHER).
Who is sponsoring clinical trial NCT07536412?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07536412's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI